Clinical Trials Study
Copyright ©The Author(s) 2024.
World J Gastroenterol. Mar 7, 2024; 30(9): 1108-1120
Published online Mar 7, 2024. doi: 10.3748/wjg.v30.i9.1108
Table 4 Effectiveness of the four most frequently used treatment regimens against the various symptoms, n (%)

MPA effectiveness, n = 3563
PPI effectiveness, n = 3563
MPA + PPI effectiveness, n = 3563
MPA + PPI + PD effectiveness, n = 3563
P value
Epigastric pain219 (55.9)155 (47.7)751 (66.7)207 (68.5)< 0.001
Abdominal distension212 (54.1)158 (48.6)608 (54.0)194 (64.2)0.001
Postprandial fullness191 (48.7)106 (32.6)455 (40.4)156 (51.7)< 0.001
Early satiety144 (36.7)59 (18.2)309 (27.4)103 (34.1)< 0.001
Acid regurgitation159 (40.6)102 (31.4)466 (41.4)164 (54.3)< 0.001
Nausea135 (34.4)61 (18.8)261 (23.2)86 (28.5)< 0.001
Belch168 (42.9)88 (27.1)355 (31.5)152 (50.3)< 0.001
Vomiting87 (22.2)38 (11.7)140 (12.4)43 (14.2)< 0.001
Others72 (18.4)14 (4.3)42 (3.7)21 (7.0)< 0.001

  • Citation: Yang YY, Li KM, Xu GF, Wang CD, Xiong H, Wang XZ, Wang CH, Zhang BY, Jiang HX, Sun J, Xu Y, Zhang LJ, Zheng HX, Xing XB, Wang LJ, Zuo XL, Ding SG, Lin R, Chen CX, Wang XW, Li JN. Clinical manifestation, lifestyle, and treatment patterns of chronic erosive gastritis: A multicenter real-world study in China. World J Gastroenterol 2024; 30(9): 1108-1120
  • URL: https://www.wjgnet.com/1007-9327/full/v30/i9/1108.htm
  • DOI: https://dx.doi.org/10.3748/wjg.v30.i9.1108